SCHEMBL4347133

SCHEMBL4347133

Oc1ccc(Cl)cc1NCc1ccccc1Sc1ccc2cccnc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.51
MEN1 O00255 6/20 0.51
CASP6 P55212 1/20 0.51
NR4A2 P43354 1/20 0.43
KDM4E B2RXH2 9/20 0.42
MAPT P10636 4/20 0.42
L3MBTL1 Q9Y468 4/20 0.42
ALDH1A1 P00352 3/20 0.42
POLB P06746 2/20 0.42
NSD2 O96028 1/20 0.42
BLM P54132 1/20 0.42
GAA P10253 1/20 0.39
RECQL P46063 1/20 0.39
APAF1 O14727 1/20 0.39
IDH1 O75874 1/20 0.38
LMNA P02545 2/20 0.38
ALOX12 P18054 2/20 0.38
HTT P42858 2/20 0.38
NPC1 O15118 1/20 0.38
MITF O75030 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4347116 0.87 GAA (0.43) KMT2AMEN1CASP6NR4A2KDM4E
SCHEMBL4344502 0.87 MEN1 (0.43) KMT2AMEN1CASP6NR4A2KDM4E
SCHEMBL4352008 0.85 KMT2A (0.43) KMT2AMEN1CASP6KDM4EMAPT
SCHEMBL4358574 0.84 HDAC6 (0.40) KMT2AMEN1CASP6NR4A2KDM4E
SCHEMBL6225665 0.84 MEN1 (0.38) KMT2AMEN1CASP6NR4A2KDM4E
SCHEMBL4347776 0.84 KMT2A (0.44) KMT2AMEN1CASP6KDM4EMAPT
SCHEMBL4355994 0.84 KMT2A (0.45) KMT2AMEN1CASP6KDM4EMAPT
SCHEMBL4347841 0.83 SLC6A4 (0.48) KMT2AMEN1CASP6KDM4EMAPT
SCHEMBL4350092 0.82 CTSD (0.38) KMT2AMEN1CASP6NR4A2KDM4E
SCHEMBL4347953 0.82 KMT2A (0.35) KMT2AMEN1CASP6NR4A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US disclosed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 KMT2A 2096/4885MEN1 2168/4885CASP6 4297/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 KMT2A 1254/4885MEN1 3901/4885CASP6 4313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.